Package leaflet: Information for the user …

Package leaflet: Information for the user Clexane …

1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes

  Clexane

small pharma code may appear on the front / back …

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.

  Pharma

PACKAGE LEAFLET: INFORMATION FOR THE USER

1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …

  Information, User, Leaflet, Packages, Package leaflet, Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER

1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains

  Information, User, Leaflet, Packages, Package leaflet, Information for the user, Information for the

Package leaflet: Information for the user - Medicines

Page 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.

Package leaflet: Information for the user …

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.

PFIZER Package leaflet: Information for the patient …

Page 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it

  Information, Leaflet, Packages, Pfizer, Information for the, Depo, Pfizer package leaflet

SAYANA PRESS 104 mg/0.65 ml suspension for …

Page 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...

  Single, Dose, Injection, Acetate, Suspension, Medroxyprogesterone, Suspension for injection medroxyprogesterone acetate single dose

PACKAGE LEAFLET: INFORMATION FOR THE USER …

PACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet

Patient Information Leaflet - Medicines

Page 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …

  Information, Patients, Leaflet, Patient information leaflet

DRUG NAME: Bendamustine - BC Cancer

Bendamustine BC Cancer Agency Cancer Drug Manual© Page 1 of 7 Bendamustine Developed: 1 May 2013 Revised: 1 September 2013; 1 September 2014 DRUG NAME: Bendamustine SYNONYM(S):

  Name, Drug, Drug name, Bendamustine

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

4 Table 1: Dosing recommendations for neutropenia Severity grade of neutropenia (signs and symptoms [abbreviated description of CTCAEa]) Modification of dosing

DIAMOX version 1 clean - Medsafe

action of acetazolamide decreases the secretion of aqueous humour and results in a drop in intraocular pressure, a reaction considered desirable in

  Version, Clean, Diamox version 1 clean, Diamox

The facts about STEVENS-JOHNSON SYNDROME …

STEVENS-JOHNSON SYNDROME (SJS) The facts about RISKS SJS and TENS are life-threatening reactions.If left untreated, they can result in death. Complications can include permanent blind-ness, dry-eye syndrome, photophobia, lung damage, chronic obstruc-

  Syndrome, Johnson, Stevens, Stevens johnson syndrome

1. Stevens-Johnson Syndrome and Toxic Epidermal …

Treatment of Severe Drug Reactions 1. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Definition SJS and TEN are variants of the same process, presenting as severe mucosal erosions

  Syndrome, Johnson, Stevens, Toxic, Epidermal, Necrolysis, Stevens johnson syndrome and toxic epidermal, Stevens johnson syndrome and toxic epidermal necrolysis

HIGHLIGHTS OF PRESCRIBING INFORMATION …

FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 EGFR Mutation-Positive, Metastatic Non-Small Cell Lung Cancer GILOTRIF is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer